Advanced Search


Study ID Status Title Patient Level Data
201718 Active, Not Recruiting WEUSKOP6069: Exploratory Cluster Analysis: Relovair COPD exacerbation studies - which patients benefit most from ICS?
201722 Completed Identification and Description of Severe Asthma Patients in a Cross-sectional Study—the IDEAL Study
201724 Active, Not Recruiting HO-14-15325 - Cost of Illness Associated with Early Combination Treatment of BPH in the US
201741 Completed A Phase 1, single-center, randomized, open-label, crossover study to assess the relative bioavailability of Phase III tablet formulation candidates in healthy adult subjects
201752 Completed A Randomized, Placebo-controlled, Double-Blind (Sponsor Unblind), Repeat Dose, Ascending Cohort, Dose Escalation Phase I Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Epelsiban and its Major Metabolite in Healthy Women Volunteers Following Administration of Repeat Dosing of Epelsiban
201761 Completed PGx7610: Genetic Evaluation of Hepatotoxicity in Pazopanib Studies
201769 Completed Exploratory Investigation of Associations between Genome-wide Genetic Variants and Response to Darapladib in the STABILITY (LPL100601) and SOLID-TIMI 52 (SB-480848/033) Trials (PGX7615)
201780 Completed A randomized, open-label, single-period, parallel-group study in healthy subjects to determine the effects of dissolution profile on the pharmacokinetics (via both venous and peripheral micro-samples) of single oral 300 mg doses of Tafenoquine (SB-252263) tablets + 30 mg Tafenoquine stable isotope labelled (SIL) solution
201794 Completed PRJ2363: Quantitative Testing of Prescriber Knowledge about TANZEUMTM (albiglutide) Safety and Use Information
201816 Active, Not Recruiting Patient Experience and Delivery Device Preferences with Belimumab: Follow up Questionnaires and Interviews to the Belimumab Subcutaneous Autoinjector Real Life Use Study in Systemic Lupus Erythematosus (SLE)
201834 Completed A randomized, double-blind, single-dose, placebo controlled, 2-way cross-over study evaluating effect of albiglutide on cholecystokinin-induced gallbladder emptying in fasting healthy subjects
201851 Completed A Pharmacokinetic Study for Systemic Exposure of Twice Daily Topically applied GSK2894512 Cream in Subjects with Atopic Dermatitis
201857 Completed Adjusting for treatment crossover in the METRIC trial comparing trametinib to dacarbazine using the ITT population (based on final data cut off)
201884 Completed Clinical Evaluation of Efficacy at 2 Weeks of Duac® Fixed Dose Combination Gel in Treatment of Facial Acne Vulgaris in Japanese Subjects
201897 Completed An Open-label, Randomized, Single Dose, Two-way Crossover study to Determine the Bioavailability of one Fixed Dose Combination Capsule Formulation of Dutasteride and Tamsulosin Hydrochloride (0.5 mg/0.2 mg) Relative to Coadministration of one Dutasteride 0.5 mg capsule and one Tamsulosin Hydrochloride 0.2 mg tablet in Healthy Male Subjects in the Fed and Fasted States
201908 Active, Not Recruiting HO-14-15413 - Evidence Synthesis and Mixed Treatment Comparison of Efficacy of Treatments for the Maintenance of Asthma (annual updates)
201909 Completed An open-label study investigating critical and overall errors following 14 days of treatment with SERETIDE Metered Dose Inhaler (EVOHALER) in adult subjects with controlled asthma currently using the SERETIDE DISKUS Inhaler Study Listed on
201929 Recruiting Efficacy of ropinirole controlled-release on the motor symptoms in advanced Parkinson’s disease patients: A post-hoc analysis of Japanese phase III clinical trial (Study ID: 201929)
201934 Completed An investigation of drug concentrations in hair and sweat of subjects with respiratory diseases following the exposure of inhaled chronic respiratory therapies as a future means of assessing treatment related compliance
201935 Recruiting Etude des conditions d'utilisation et du profil de securite de'allli OR Study of the conditions of use and safety profile of Alli
201955 Completed Incidence of Gall Bladder Related Events Among Type 2 Diabetes Patients
201958 Completed An open label, six-period cross-over, single and repeat dose study to determine the pharmacokinetics of fluticasone furoate and GSK961081 when administered alone, in combination, or concurrently via the ELLIPTA
201959 Completed A Phase III study for the evaluation of the immunogenicity and reactogenicity of GSK Biologicals' Quadrivalent Split Virion Influenza Vaccine Fluarix Tetra (2015 season Southern Hemisphere) in adults 18 years of age and above Study Listed on
201974 Completed A study to evaluate safety, reactogenicity and immunogenicity of GSK Biologicals’ RSV investigational vaccine based on viral proteins encoded by chimpanzee-derived adenovector (ChAd155-RSV) (GSK3389245A) in healthy adults
201986 Completed PGx7611: Genetic Investigation of ALT elevations in Eltrombopag studies in ITP subjects



For more information on this register please email

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party. is a database that provides summary protocol information for ongoing clinical trials. is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.